SERVICES
To support in vivo CAR-T and other in vivo cell therapy applications, Levostar provides an integrated mRNA delivery solution spanning mRNA plasmid construction, IVT RNA synthesis, LNP encapsulation, and T cell–targeted mRNA-tLNP development.
By combining high-quality mRNA production with robust lipid nanoparticle formulation and targeted delivery strategies, Levostar enables efficient in vivo delivery and functional expression of CAR-encoding RNA, supporting systematic development from early research to translational studies.
Levostar Biotech
Levostar Biotech is a technology-driven biotechnology company advancing in vivo CAR-T and next-generation cell and gene therapies through mRNA–LNP–based engineering solutions.
Leveraging proprietary mRNA synthesis, targeted lipid nanoparticle (tLNP) delivery, and in vivo functional validation platforms, we provide integrated services from DNA to RNA, delivery, and in vivo CAR-T characterization, accelerating the development and translation of innovative therapies.
With operations in China and the United States, Levostar Biotech supports global biopharmaceutical partners in bringing transformative medicines to patients.
E-mail：support@levostar.com
USA
16192 Coastal Hwy，Lewes, DE 19958
TEL：619-537-9202
China
A3-502 No.328, Xinghu Street, Suzhou Industrial Park, Suzhou, Jiangsu, China 215123
TEL：0512-62888898